RI-OR2-TAT, CAS [[1430219-69-4]] Preis auf Anfrage

Artikelnummer: TGM-TP3015
Artikelname: RI-OR2-TAT, CAS [[1430219-69-4]] Preis auf Anfrage
Artikelnummer: TGM-TP3015
Hersteller Artikelnummer: TP3015
Alternativnummer: TGM-TP3015-10MG, TGM-TP3015-50MG
Hersteller: TargetMol
Kategorie: Biochemikalien
RI-OR2-TAT is a brain-penetrable inhibitor targeting beta-amyloid (beta-Amyloid) oligomerization. It is engineered by integrating the HIV protein transduction domain TAT into RI-OR2. RI-OR2-TAT binds to Abeta42 fibrils with a Kd value of 58-125 nM. It reduces Abeta aggregation and plaque levels, diminishes microglial activation and oxidative damage, and enhances the number of young neurons in the dentate gyrus.
Molekulargewicht: 2662.16
CAS Nummer: [1430219-69-4]
Formel: C117H201N49O23
Target-Kategorie: Others|||Beta Amyloid
TP3015